The National Medical Products Administration (NMPA) announced the marketing approvals for COVID-19 antigen detection reagents by Bioda Diagnostics (Wuhan) Co., Ltd, Getein Biotech, Inc, Triplex International Biosciences (China) Co., Ltd, and Zhongshan Bio-Tech Co., Ltd. A total of 40 such products have now been approved in China to date.
Product Details and Usage
COVID-19 antigen detection reagents can be used for the in vitro qualitative detection of COVID-19 antigens via nasopharyngeal swabs, oropharyngeal swabs, or nasal swabs. The negative results of antigen detection cannot exclude COVID-19 infection, and nucleic acid detection is still the diagnosis basis for COVID-19 infection.-Fineline Info & Tech
